![](https://www.diabetesnews.com/wp-content/uploads/2014/05/obese-6380-150x150.jpg)
GIP and GLP-1 are substances produced in the body’s digestive tract, and they play important roles in regulating body weight and food intake. A recently published study on their effects suggests that they may one day be used to develop drugs to treat obesity and type 2 diabetes. Read more